- Home
- ABTS vs EVGN Comparison
ABTS vs EVGN Comparison
Compare ABTS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- EVGN
- Stock Information
- Founded
- ABTS 2010
- EVGN 1999
- Country
- ABTS Hong Kong
- EVGN Israel
- Employees
- ABTS N/A
- EVGN N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- EVGN Agricultural Chemicals
- Sector
- ABTS Technology
- EVGN Industrials
- Exchange
- ABTS Nasdaq
- EVGN Nasdaq
- Market Cap
- ABTS 9.8M
- EVGN 11.4M
- IPO Year
- ABTS N/A
- EVGN N/A
- Fundamental
- Price
- ABTS $4.21
- EVGN $1.35
- Analyst Decision
- ABTS
- EVGN Strong Buy
- Analyst Count
- ABTS 0
- EVGN 1
- Target Price
- ABTS N/A
- EVGN $3.50
- AVG Volume (30 Days)
- ABTS 16.7K
- EVGN 84.1K
- Earning Date
- ABTS 08-13-2025
- EVGN 08-19-2025
- Dividend Yield
- ABTS N/A
- EVGN N/A
- EPS Growth
- ABTS N/A
- EVGN N/A
- EPS
- ABTS N/A
- EVGN N/A
- Revenue
- ABTS $7,037,156.00
- EVGN $6,765,000.00
- Revenue This Year
- ABTS N/A
- EVGN N/A
- Revenue Next Year
- ABTS N/A
- EVGN $113.18
- P/E Ratio
- ABTS N/A
- EVGN N/A
- Revenue Growth
- ABTS 31.69
- EVGN N/A
- 52 Week Low
- ABTS $1.35
- EVGN $0.95
- 52 Week High
- ABTS $14.10
- EVGN $4.22
- Technical
- Relative Strength Index (RSI)
- ABTS 49.33
- EVGN 55.03
- Support Level
- ABTS $3.87
- EVGN $1.18
- Resistance Level
- ABTS $4.44
- EVGN $1.37
- Average True Range (ATR)
- ABTS 0.33
- EVGN 0.07
- MACD
- ABTS 0.00
- EVGN 0.02
- Stochastic Oscillator
- ABTS 65.74
- EVGN 91.67
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.